Cargando…
Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer—An Analysis of the NOGGO/JAGO
SIMPLE SUMMARY: Patients diagnosed with early-stage ovarian cancer (OC) are treated by surgery and, if appropriate, by adjuvant chemotherapy. However, in practice, there is disagreement about both the extent of surgical staging and the indication of adjuvant chemotherapy. Therefore, we sought to str...
Autores principales: | Heublein, Sabine, Baum, Joanna, Jaeger, Anna, Grimm-Glang, Donata, Olthoff, Julia, Braicu, Elena Ioana, Azzam Nieto, Osama, Hassdenteufel, Kathrin, Schmalfeldt, Barbara, Hanker, Lars, Wallwiener, Markus, Schneeweiss, Andreas, Sehouli, Jalid, Pietzner, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093615/ https://www.ncbi.nlm.nih.gov/pubmed/37046699 http://dx.doi.org/10.3390/cancers15072038 |
Ejemplares similares
-
Real-World Evidence: How Long Do Our Patients Fast?—Results from a Prospective JAGO-NOGGO-Multicenter Analysis on Perioperative Fasting in 924 Patients with Malignant and Benign Gynecological Diseases
por: Beck, Maximilian Heinz, et al.
Publicado: (2023) -
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group
por: Trillsch, Fabian, et al.
Publicado: (2021) -
Results of a German wide survey towards current surgical approach in early stage cervical cancer NOGGO MONITOR 11
por: Armbrust, Robert, et al.
Publicado: (2021) -
Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
por: Fotopoulou, Christina, et al.
Publicado: (2012) -
Bevacizumab Combined with Platinum–Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients
por: Sehouli, Jalid, et al.
Publicado: (2021)